Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain

Archives of General Psychiatry

Volumn 61, Issue 6, 2004, Pages 544-555

  Weickert, Cynthia Shannon ^a   Straub, Richard E ^a   McClintock, Benjamin W ^a   Matsumoto, Mitsuyuki ^b   Hashimoto, Ryota ^c   Hyde, Thomas M ^a   Herman, Mary M ^a   Weinberger, Daniel R ^a   Kleinman, Joel E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b ASTELLAS PHARMA INC   (Japan)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; MESSENGER RNA; PROTEIN; SPINOPHILIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DYSBINDIN GENE; EVIDENCE BASED MEDICINE; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; IN SITU HYBRIDIZATION; INTRON; MALE; MENTAL PATIENT; MESENCEPHALON; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PROMOTER REGION; PUTAMEN; QUANTITATIVE ANALYSIS; RISK FACTOR; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TEMPORAL CORTEX; THALAMUS;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADULT; AGED; AUTORADIOGRAPHY; BLOTTING, NORTHERN; BRAIN; CARRIER PROTEINS; CYCLOPHILINS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; INTRONS; MALE; MESENCEPHALON; MICROFILAMENT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PREFRONTAL CORTEX; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SCHIZOPHRENIA; SYNAPTOPHYSIN;

EID: 2942590969     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.61.6.544     Document Type: Article

References (71)

1. Cloninger CR. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci U S A. 2002;99:13365-13367.
2. Harrison PJ, Owen MJ. Genes for schizophrenia? recent findings and their pathophysiological implications. Lancet. 2003;361:417-419.
3. Mowry BJ, Nancarrow DJ. Molecular genetics of schizophrenia. Clin Exp Pharmacol Physiol. 2001;28:66-69.
4. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 2001;50:825-844.
5. Bunney WE, Bunney BG. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res Brain Res Rev. 2000;31:138-146.
6. Jones LB. Recent cytoarchitechtonic changes in the prefrontal cortex of schizophrenics. Front Biosci. 2001;6:E148-E153.
7. Lewis DA, Gonzalez-Burgos G. Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia. Brain Res Bull. 2000;52:309-317.
8. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45:17-25.
9. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis. 2001;8:723-742.
10. Sillitoe RV, Benson MA, Blake DJ, Hawkes R. Abnormal dysbindn expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. J Neurosci. 2003;23:6576-6585.
11. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem. 2001;276:24232-24241.
12. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet. 2002;71:337-348.
13. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 2003;72:185-190.
14. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF, Feng GY, Xing YL, Shi JG, He L. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry. 2003;8:717-718.
15. Hudson TJ. Wanted: regulatory SNPs. Nat Genet. 2003;33:439-440.
16. Watkins SC, Cullen MJ, Hoffman EP, Billington L. Plasma membrane cytoskeleton of muscle: a fine structural analysis. Microsc Res Tech. 2000;48:131-141.
17. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, Sanes JR. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron. 2000;25:279-293.
18. Adams ME, Kramarcy N, Krall SP, Rossi SG, Rotundo RL, Sealock R, Froehner SC. Absence of α-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J Cell Biol. 2000;150:1385-1398.
19. Blake DJ, Kroger S. The neurobiology of Duchenne muscular dystrophy: learning lessons from muscle? Trends Neurosci. 2000;23:92-99.
20. Claudepierre T, Dalloz C, Mornet D, Matsumura K, Sahel J, Rendon A. Characterization of the intermolecular associations of the dystrophin-associated glycoprotein complex in retinal Muller glial cells. J Cell Sci. 2000;113(pt 19):3409-3417.
21. Moukhles H, Carbonetto S. Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain. J Neurochem. 2001;78:824-834.
22. Peters MF, O'Brien KF, Sadoulet-Puccio HM, Kunkel LM, Adams ME, Froehner SC. β-dystrobrevin, a new member of the dystrophin family: identification, cloning, and protein associations. J Biol Chem. 1997;272:31561-31569.
23. Li W, Zhang Q, Oiso N, Novak E, Gautam R, O'Brien E, Tinsley C, Blake D, Spritz R, Copelan N, Jenkins N, Amato D, Roe B, Starcevic M, Dell'Anglelica E, Elliott R, Mishra V, Kingsmore S, Paylor R, Swank R. Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet. 2003;35:84-89.
24. Blank M, Blake DJ, Kroger S. Molecular diversity of the dystrophin-like protein complex in the developing and adult avian retina. Neuroscience. 2002;111:259-273.
25. Weickert CS, Kleinman JE. The neuroanatomy and neurochemistry of schizophrenia. Psychiatr Clin North Am. 1998;21:57-75.
26. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry. 2000;57:907-913.
27. Weinberger DR, Berman KF. Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci. 1996;351:1495-1503.
28. Weickert CS, Webster MJ, Hyde TM, Herman MM, Bachus SE, Bali G, Weinberger DR, Kleinman JE. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cereb Cortex. 2001;11:136-147.
29. Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003;8:592-610.
30. Thompson PM, Sower AC, Perrone-Bizzozero NI. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol Psychiatry. 1998;43:239-243.
31. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 1995;52:805-818.
32. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol. 1998;392:402-412.
33. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55:215-224.
34. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 2001;58:466-473.
35. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53-67.
36. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for "hypofrontality. " Mol Psychiatry. 1999;4:39-45.
37. Honer WG, Falkai P, Chen C, Arango V, Mann JJ, Dwork AJ. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness. Neuroscience. 1999;91:1247-1255.
38. Kleinman JE, Hyde TM, Herman MM. Methodological issues in the neuropathology of mental illness. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press Ltd; 1995:859-864.
39. Zalcman S, Endicott J, Clayton P, Winokur G. Diagnositc Evaluation After Death (DEAD). Rockville, Md: National Institute of Mental Health; 1983.
40. Keks NA, Hill C, Opeskin K, Copolov D, Dean B. Psychiatric diagnosis after death: the problems of accurate diagnosis from case history review and relative interviews. In: Dean B, Kleinman JE, eds. Using CNS Tissue in Psychiatric Research: A Practical Guide. Amsterdam, the Netherlands: Overseas Publishers Association; 1999:19-37.
41. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Brain Res Mol Brain Res. 1995;29:157-162.
42. Ozcelik T, Lafreniere RG, Archer BT III, Johnston PA, Willard HF, Francke U, Sudhof TC. Synaptophysin: structure of the human gene and assignment to the X chromosome in man and mouse. Am J Hum Genet. 1990;47:551-561.
43. Sudhof TC, Lottspeich F, Greengard P, Mehl E, Jahn R. The cDNA and derived amino acid sequences for rat and human synaptophysin. Nucleic Acids Res. 1987;15:9607.
44. Whitfield HJ Jr, Brady LS, Smith MA, Mamalaki E, Fox RJ, Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell Mol Neurobiol. 1990;10:145-157.
45. McGuigan FE, Ralston SH. Single nucleotide polymorphism detection: allelic discrimination using TaqMan. Psychiatr Genet. 2002;12:133-136.
46. Allen PB, Ouimet CC, Greengard P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci U S A. 1997;94:9956-9961.
47. Lidow MS, Song ZM, Castner SA, Allen PB, Greengard P, Goldman-Rakic PS. Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex. Biol Psychiatry. 2001;49:1-12.
48. Arnold S, Talbot K, Eidem W, Benson M, Trojanowski J, Blake D, Uryu K. Dysbindin distribution in the brain of rodents and humans. In: 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience; 2003. Program No. 447.4.
49. Talbot K, Eidem W, Benson M, Smith R, Trojanowski J, Gur R, Hahn C, Blake D, Arnold S. Dysbindin and vesicular glutamate transporter-1 (VGLUT-1) are altered in the hippocampal formation in schizophrenia. In: 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience; 2003. Program No. 447.5.
50. Harrison PJ, Eastwood SL. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus. 2001;11:508-519.
51. Blum PB, Mann JJ. The GABAergic system in schizophrenia. Int J Neuropsychopharmacol. 2002;5:159-179.
52. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry. 1992;149:890-897.
53. Grossberg S. The imbalanced brain: from normal behavior to schizophrenia. Biol Psychiatry. 2000;48:81-98.
54. Kosaka H, Omori M, Murata T, Iidaka T, Yamada H, Okada T, Takahashi T, Sadato N, Itoh H, Yonekura Y, Wada Y. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophr Res. 2002;57:87-95.
55. Gur RE, McGrath C, Chan RM, Schroeder L, Turner T, Turetsky BI, Kohler C, Alsop D, Maldjian J, Ragland JD, Gur RC. An fMRI study of facial emotion processing in patients with schizophrenia. Am J Psychiatry. 2002;159:1992-1999.
56. Koh PO, Bergson C, Undie AS, Goldman-Rakic PS, Lidow MS. Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. Arch Gen Psychiatry. 2003;60:311-319.
57. Halim ND, Weickert CS, McClintock BW, Hyde TM, Weinberger DR, Kleinman JE, Lipska BK. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry. 2003;8:797-810.
58. Glantz LA, Austin MC, Lewis DA. Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 2000;48:389-397.
59. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of gene in human brain. Hum Genet. 2003;113:149-153.
60. Gorecki DC, Monaco AP, Derry JM, Walker AP, Barnard EA, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet. 1992;1:505-510.
61. Gorecki DC, Derry JM, Barnard EA. Dystroglycan: brain localisation and chromosome mapping in the mouse. Hum Mol Genet. 1994;3:1589-1597.
62. Brunig I, Suter A, Knuesel I, Luscher B, Fritschy JM. GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. J Neurosci. 2002;22:4805-4813.
63. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 1995;52:829-836.
64. Block W, Bayer TA, Tepest R, Traber F, Rietschel M, Muller DJ, Schulze TG, Honer WG, Maier W, Schild HH, Falkai P. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett. 2000;289:147-151.
65. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 1998;43:641-648.
66. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 1996;153:1554-1563.
67. Weickert CS, Ligons DL, Romanczyk T, Ungaro G, Hyde TM, Herman M, Weinberger DR, Kleinman JE. Neurotrophin receptor mRNA in patients with schizophrenia: insights into cellular pathology of the prefrontal cortex. Mol Psychiatry. In press.
68. Ohnuma T, Kato H, Arai H, Faull RL, McKenna PJ, Emson PC. Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport. 2000;11:3133-3137.
69. Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K, Nakamura R, Niizato K, Watanabe M, Kakita A, Takahashi H, Someya T, Nawa H. Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem. 2002;83:797-806.
70. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65-73.
71. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR, Hirsch SR. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446-453.